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Adult urodele amphibians possess the unique ability to regenerate amputated limbs and to re-innervate these regenerating structures;
however, the factors involved in mediating this re-innervation are largely unknown. Here, we investigated the role of retinoic acid (RA) and
one of its receptors, RARh, in the reciprocal neurotropic interactions between regenerating limb blastemas and spinal cord explants from the
adult newt Notophthalmus viridescens. First, we showed that retinoic acid induced directed axonal outgrowth from cultured spinal cord
tissue. This RA-induced outgrowth was significantly reduced when spinal cord explants were pre-treated with either the synthetic RAR pan
antagonist, LE540, or the specific RARh antagonist, LE135. The role of RARh was also investigated using co-cultured regenerating limb
blastemas and spinal cord explants. Blastemas induced significantly more axonal outgrowth from the near side of co-cultured explants, than
from the far side (when cultured less than 1 mm apart). This blastema-induced directed outgrowth from co-cultured spinal cord explants was
also abolished in the presence of the RARh antagonist, LE135. These data strongly suggest that endogenous retinoic acid is one of the tropic
factors produced by the blastema and that it may be capable of guiding re-innervating axons to their targets. Moreover, this interaction is
likely mediated by the retinoic acid h nuclear receptor.
D 2005 Elsevier Inc. All rights reserved.
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Adult urodele amphibians possess a unique capability:
the ability to regenerate a number of lost structures such as
limbs and spinal cord (Nye et al., 2003). In order to produce
a functional limb after amputation, newly formed structures
must be re-innervated by appropriate nerves (Singer, 1952).
Therefore, a regenerating limb must produce an environ-
ment conducive to axonal growth, which would provide
appropriate cues to the axons, allowing for accurate target
innervation (Wilson et al., 1989).
It has been suggested that during limb regeneration in
urodeles, correct re-innervation requires reciprocal signaling
between re-innervating nerves and the undifferentiated mass0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.02.019
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E-mail address: rcarlone@brocku.ca (R.L. Carlone).of mesenchymal cells known as the regeneration blastema
(Bauduin et al., 2000; Pollack et al., 1981). Re-innervating
nerves from the spinal cord may provide mitogenic
factor(s), such as substance P, transferrin, glial growth
factor, and/or fibroblast growth factor to the blastema cells,
in order to stimulate and maintain their proliferation
(Stocum, 2004). In turn, to guide re-innervating nerves to
their appropriate targets, the blastema may produce diffu-
sible neurotropic molecule(s) (Bauduin et al., 2000; Tonge
and LeClere, 2000). Many neurotrophins have been ruled
out as the chemoattractants in the reciprocal interaction
between regenerating limb blastemas and spinal cord
neurons (Tonge and LeClere, 2000). However, the role of
small diffusible non-protein factors, such as the Vitamin A
metabolite, retinoic acid (RA), has not yet been conclusively
determined.
There is currently strong evidence to support a role for
RA in growth and differentiation of many embryonic cell281 (2005) 112–120
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embryonic spinal cord is a rich source of RA (Maden et al.,
1998) and RA-deficient quail embryos show little or no
outgrowth from the spinal cord to the periphery (Maden et
al., 1996). RA can direct neurite outgrowth from embryonic
chick dorsal root ganglia neurons in vitro (Maden et al.,
1998), and induces neurite outgrowth from larval salaman-
der (Hunter et al., 1991) and embryonic mouse spinal cord
(Corcoran et al., 2002) cultures. RA-induced neurite out-
growth is mediated by members of the RAR family of
nuclear receptors (Corcoran et al., 2000), particularly
through the upregulation of a specific receptor subtype,
RARh2 (Corcoran et al., 2002).
However, in the adult mouse, cultured spinal cord
neurons do not extend axons even in the presence of RA,
nor do they upregulate RARh2, presumably due to tran-
scriptional inactivation of this gene in the adult (Corcoran et
al., 2002). Urodele amphibians, on the other hand, differ
from these species described above, in that they can
regenerate CNS tissues in the adult. Though RA has been
shown to play a role in neurite outgrowth from larval axolotl
spinal cord in vitro (Hunter et al., 1991), its precise role in
regeneration from the adult spinal cord is unclear. We
recently provided evidence that the neurotropic activity of
cultured limb blastemas on spinal cord neurons from the
adult newt may involve endogenous RA (Prince and
Carlone, 2003). In this previous study, blastemas were
pre-treated with citral, an inhibitor of retinaldehyde dehy-
drogenase (a key enzyme in the synthesis of endogenous
RA; Duester, 2000), and then co-cultured with spinal cord
explants. We showed that the neurotropic activity of the
citral-treated blastemas was reduced by more than 40%
(Prince and Carlone, 2003). This previous study strongly
suggested that RA was an important factor involved in
regeneration of adult spinal cord explants, though the
possibility that RA was exerting indirect effects was not
ruled out. In the present study, our main aim was to
investigate the direct role of RA in the neurotropic and
chemotactic interaction between regenerating limb blaste-
mas and spinal cord explants from the adult newt,
Notophthalmus viridescens. In particular, with the use of
selective RA receptor antagonists, we aimed to determine
whether blastema-derived retinoic acid induced directed
neurite outgrowth from spinal cord explants by acting
through the RARh receptor.Materials and methods
Limb amputation and blastema removal
Adult red-spotted newts, N. viridescens, were supplied
by Boreal Labs (St. Catharines, ON). All protocols were
approved by the Brock University Animal Care and Use
Committee. Newts were anesthetized by placing them in an
aqueous solution of 3-amino benzoic acid ethyl ester (0.1%w/v) (Sigma). The skin was sterilized by brief immersion in
chloramine T (0.1% w/v) (Sigma) followed by a brief rinse
in sterile amphibian Ringer’s solution. All equipment used
during spinal cord removal was sterilized in 70% ethanol
and flamed. Limb amputations were made just proximal to
the wrist of both forearms. Early blastemas were removed
8 days after the original amputation for primary blastemas.
In order to test whether the quality or quantity of
neurotropic factors differ after reamputation of the blas-
tema at the stump–blastema interface, secondary blastemas
were removed 6 days after the amputation of primary
blastemas. Secondary blastemas reach equivalent morpho-
logical stages more quickly than primary blastemas
(Wallace, 1981). Blastemas were immediately immersed
in amphibian Ringer’s solution containing antibiotic and
antimycotic (GIBCO). They were then briefly placed in
chloramine T solution (1.0% w/v) followed by a rinse in
sterile amphibian Ringer’s solution (with antibiotic and
antimycotic), and then cultured.
Spinal cord removal and culture
After anesthesia and sterilization, newts were decapitated
and the spinal column was carefully dissected along the full
length of the body. The spinal column was sterilized by brief
immersion in chloramine T (0.1% w/v), followed by a rinse
in sterile amphibian Ringer’s solution (with antibiotic and
antimycotic). Vertebrae were pulled apart with fine forceps
to remove the spinal cord from the spinal column. The
isolated spinal cord was placed in amphibian Ringer’s
solution containing antibiotic and antimycotic for 10 min.
While in the Ringer’s solution, the meninges were removed
with fine forceps and the spinal cord was cut with a scalpel
into transverse sections approximately 0.5 mm thick. The
spinal cord sections were then submerged in a chloramine T
solution (0.1% w/v) for 30 s to ensure sterility, rinsed in
sterile amphibian Ringer’s solution (with antibiotic and
antimycotic), and then rinsed in L-15 defined medium.
Spinal cord sections were then cultured immediately, as
explained below.
Culture conditions
Spinal cord explants were cultured on poly-l-lysine-
coated (Sigma) glass coverslips (Belco) in 35-mm culture
dishes (Fisher). A maximum of three spinal cord sections
were cultured in each dish. To facilitate attachment of the
spinal cord to the dish, the explants were cultured for the
first 10 min in a minimal volume of medium. Once the
spinal cord became attached, the volume of the medium
was adjusted to 3 ml, which was sufficient to cover the
explant. Explants were cultured in 70% Leibovitz L-15
medium (GIBCO). The defined medium was supplemented
with 1% glucose, 300 ng/ml glutamine, 125 U/ml
penicillin, 125 Ag/ml streptomycin, 0.14 U/ml insulin (all
GIBCO), 6.3 ng/ml progesterone (Sigma), and 5 Ag/ml
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adjusted to 7.5–7.6.
Due to the light-sensitivity of RA, all-trans-RA (Sigma)
stocks were prepared fresh in absolute ethanol in the dark.
The treatment of spinal cord explants with RA and/or
various chemicals was performed immediately following
attachment. Control cultures received the appropriate
volume of EtOH vehicle. The cultures were maintained at
258C F 18C in a humidified atmosphere in the dark.
Synthetic RA receptor antagonists LE135 and LE540
were kindly donated by S. Kagechika (U. of Tokyo). Both
antagonists are dibenzodiazapine derivatives. LE135 can
bind selectively to RARa and RARh with higher affinity for
RARh (Eyrolles et al., 1994; Kagechika, 2002). LE135
inhibits the retinoic acid-induced differentiation of human
promyelocytic leukemia cells (Eyrolles et al., 1994) at
concentrations similar to those utilized in this study, and
disrupts normal patterning during limb regeneration in the
axolotl (Del Rincon and Scadding, 2002). Antagonists were
dissolved in DMSO and diluted to the final concentration
(2  106 M) in defined medium. Stock concentrations
(2 mM) were stored at 208C. Antagonists were added to
spinal cord explants at least 1 h before the addition of
either the blastemas or the RA. In the absence of RA and/
or antagonists, vehicle (EtOH and DMSO, respectively)
concentrations were adjusted to equal those containing the
appropriate agents.
Chemotaxis: RA beads or blastemas co-cultured with newt
spinal cord explants
AG 1-X2 beads (BioRad) were washed several times in
1  PBS buffer, and soaked in RA (4 mg/ml) dissolved in
absolute ethanol. Vehicle control beads were soaked in
absolute ethanol. All beads were soaked for 72 h in the
dark and stored at 208C. Beads were washed three times
in culture medium, and plated in separate dishes for each
experiment, no further than 1 cm from the spinal cord
explants. Blastemas (primary or secondary) were plated
approximately 1 mm from newly attached spinal cord
explants. All blastema–spinal cord co-cultures contained
DMSO, as it was the vehicle solution for the antagonist
used in the study.Fig. 1. RA induced axonal outgrowth in adult newt spinal cord explants. Photos t
(C) 107 M RA. Scale bar = 50 Am.Analysis of axon outgrowth
All cultures were examined for axonal outgrowth 72 h
following spinal cord culture. Cultures were viewed with a
Zeiss Axiovert 200 inverted microscope, using a digital
camera and Northern Eclipse (Empix Imaging, ON) imaging
software. All results were expressed as mean F the standard
error of the mean. In RA and antagonist cultures, data were
analyzed using a one-way analysis of variance (ANOVA)
and Dunn’s Post Hoc test, and considered significant when
P b 0.05. For blastema and/or RA-bead co-cultures, the
difference in number of axons between each side of the
explant was calculated in each condition and the values
compared using a 1-way ANOVA, and Dunn’s Post Hoc
test, and considered significant when P b 0.05.Results
RA induced directed neurite outgrowth from adult newt
spinal cord explants in vitro
In order to determine whether RA induces outgrowth of
neurites from the adult newt spinal cord, explants were
cultured in either 107 M RA, defined medium alone or
vehicle solutions (no treatment controls) and examined after
72 h in culture. Explants in control conditions extended few
axons (defined medium: 23 F 3.5 neurites, n = 21 explants,
Fig. 1A; EtOH: 16.8 F 2.3 neurites, n = 16 explants, Fig.
1B), but the number of axons was not significantly different
between the two control conditions. In contrast, the RA-
treated explants extended significantly more axons than
controls (53.4 F 8.2 neurites, n = 13 explants, P b 0.01,
Fig. 1C). These results support our previous findings that
RA induces neuronal outgrowth from adult newt spinal cord
explants in vitro (Prince and Carlone, 2003).
In order to determine if RA acts as a chemoattractant for
regenerating nerves, we cultured spinal cord explants with
an exogenous source of RA, and monitored the explants for
directed axonal outgrowth 72 h later. AG-1X2 beads,
soaked in either RA or absolute ethanol, were plated to
one side of the cultured spinal cord explants. The beads
produce a continual source of either RA or vehicle (Tickleaken 72 h after treatment with (A) defined culture medium, (B) EtOH, and
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of neurites on the side of the explant closest to the RA
bead, compared to the side furthest from the bead (P b
0.01, n = 23 explants; Fig. 2). In contrast, there was no
significant increase in number of neurites on the side of the
explant closest to the control bead, compared to the side
furthest from the control bead (n = 27 explants; Fig. 2).
These results strongly suggest that a concentration gradient
of RA affects the direction of neuronal outgrowth from the
adult newt spinal cord explants.
Limb blastema-induced directed outgrowth from spinal cord
explants
Our previous study (Prince and Carlone, 2003) suggested
that retinoic acid produced by the blastema induces neurite
outgrowth from spinal cord explants. We next wished to
determine whether the regeneration blastema could also
induce directed outgrowth (chemotaxis) from the cultured
explants, and thus mimic the effects of RA shown above.
For this purpose, we investigated the neurite-inducing
effects of both primary and secondary blastemas. Primary
blastemas were obtained from an original amputation
whereas secondary blastemas arise after removal of the
original limb blastema. There was significantly more out-
growth (P b 0.01) when spinal cord explants were co-
cultured with primary blastemas (85 F 7 neurites, n = 27
explants) or secondary blastemas (40 F 7, n = 29 explants),
than explants cultured in the absence of blastemas (23 F 3.5
neurites, n = 21 explants). However, we also showed that
primary blastemas induced significantly more outgrowthFig. 2. RA-soaked beads induced directed axonal outgrowth. Above:
diagrammatic representation of spinal cord and bead locations (RA 1, 2 or
EtOH 3, 4). Below: graph depicting increase in axonal outgrowth from side
of adult spinal cord explant closest to RA-soaked bead. **There was a
significant increase in number of axons on the side of the explant exposed
to the RA bead (P b 0.01) versus all other sides.than secondary blastemas (P b 0.01). All culture conditions
with blastemas contained DMSO (b0.1% w/v) as vehicle
unless otherwise stated.
By comparing the neurite outgrowth from the explant side
closest to the blastema, to the explant side farthest from the
blastema, we were next able to determine whether either the
primary or secondary blastema was capable of inducing
directed outgrowth. Indeed, we found that directed outgrowth
(chemotaxis) was observed when either the primary (n = 14
explants) or secondary blastemas (n = 13 explants) were
positioned less than 1 mm from the explants (P b 0.01; Figs.
3A, B; see Table 1 for near side and far side data). To
determine if the chemotactic responsewas distance dependent,
the blastemas and spinal cord explants were next co-cultured
up to 1 cm apart. At this distance, the blastema continued to
induce outgrowth, but this outgrowth was not directed as it
was not limited to one side of the explant (see Table 1). Thus,
at distances greater than 1 mm, the chemotactic response of
spinal cords to both primary and secondary blastemas was
significantly diminished (P b 0.01; Figs. 3C, D).
These data strongly suggest that the blastema (both
primary and secondary) can induce directed outgrowth that
is distance dependent. This may be due to a concentration-
dependent phenomenon of a diffusible factor, such as RA,
capable of directing outgrowth. Fig. 4 demonstrates the
ability of both RA-soaked beads and secondary blastemas,
when cultured less than 1 mm from the explant, to direct
neurite outgrowth.
RA-induced outgrowth is mediated by a member of the
RARb receptor family
RA has been shown to induce axon outgrowth via its
nuclear receptor, RARh (Corcoran and Maden, 1999). In
order to determine whether RA-induced neuronal outgrowth
is mediated by RARh, spinal cord explants were cultured in
the presence of RA and either LE540 (RAR a, h or g) or
LE135 (RARh receptor antagonist; Fig. 5). In the presence
of 107 M RA (and antagonist vehicle), spinal cords
extended an average of 47 F 4 axons (n = 29 explants;
Fig. 5). This outgrowth was significantly decreased in the
presence of both LE135 (13F 3 axons; n = 28 explants; P b
0.01; Fig. 5) and LE540 (27F 5 axons; n = 29 explants; P b
0.05; Fig. 5). The antagonists had no significant effect in the
absence of RA (Fig. 5). There was also no significant
difference in the number of axons found in the control
medium containing only vehicle solutions (Fig. 5). These
results strongly suggest that the RA-induced outgrowth from
adult newt spinal cord explants was mediated by a member
of the RARh class of nuclear receptors.
Limb blastema-induced neuronal outgrowth in spinal cord
explants is also mediated by RARb
Here, we aimed to determine whether the directed
outgrowth induced by either primary or secondary blaste-
Fig. 3. Primary blastema and spinal cord co-cultures induced directed axonal outgrowth at distances less than 1 mm. Above: diagrammatic representation of
spinal cord and blastema locations (less than 1 mm: A, B, or more than 1 mm: C, D). Below: representative photos of spinal cord explants taken 72 h after co-
cultured primary blastema is (A) less than 1 mm to the left of an explant, where (B) shows the right side of the same explant, (C) more than 1 mm to the left of a
different explant, where (D) shows the right side of the same explant. Scale bar = 50 Am.
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found that the total number of axons extending from spinal
cord explants co-cultured with a primary blastema was
reduced by 61% in the presence of LE135 (33 F 5 neurites,
n = 33 explants, P b 0.01; Fig. 6). In secondary blastema
co-cultures, LE135 reduced the total number of blastema-
induced neurites by 67.5% to an average of 13 F 3 (n = 27
explants, P b 0.01; Table 1). Furthermore, the outgrowth
that was observed was no longer directed outgrowth. That
is, in the presence of LE135, the number of neurites
extending from the side of the explant closest to the
blastema was no longer significantly different from that
extending from the far side of the explant (see Table 1).
These results strongly suggest that the neurite-inducingchemotactic effects of the regeneration blastema are
mediated by RA acting through the RARh receptor.Discussion
Previous studies have shown that regenerating limb
blastemas and limb buds from amphibians are capable of
eliciting axon outgrowth from spinal cord and dorsal root
ganglion explants (Bauduin et al., 2000; Prince and Carlone,
2003; Tonge and LeClere, 2000; Tonge et al., 2004).
Despite attempts to elucidate their chemical nature, the
identity of the nerve growth-inducing factors produced by
limb buds or blastemas remains unclear.
Table 1
Primary blastema and spinal cord co-cultures induced significantly more
total axonal outgrowth than secondary blastemas
Condition # Axons Near side
# axons
Far side
# axons
n
Explant alone 23 F 4 n/a n/a 21
Explant far blast 18 + DMSO 95 F 9 46 F 6 49 F 6 13
Explant far blast 18 + LE135 39 F 7 17 F 4 22 F 4 11
Explant close blast 18 + DMSO 75 F 11 48 F 7 27 F 5 14
Explant close blast 18 + LE135 30 F 6 17 F 4 13 F 3 22
Explant far blast 28 + DMSO 57 F 11 30 F 6 27 F 6 16
Explant far blast 28 + LE135 17 F 6 8 F 4 9 F 3 13
Explant close blast 28 + DMSO 18 F 2 13 F 2 5 F 1 13
Explant close blast 28 + LE135 8 F 2 4 F 1 5 F 1 14
Explant totala blast 18 + DMSO 85 F 7 47 F 4 38 F 4 27
Explant totala blast 18 + LE135 33 F 5 17 F 3 16 F 2 33
Explant totala blast 28 + DMSO 40 F 7 22 F 4 17 F 4 29
Explant totala blast 28 + LE135 13 F 3 6 F 2 7 F 2 27
a Total blastema data represent the average of the combined far and close
co-culture data.
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demonstrating a potential role for endogenous RA in
regenerating limb blastema-induced axon outgrowth of
adult spinal cord neurons (Prince and Carlone, 2003). We
previously showed that when the synthesis of RA in the
blastema mesenchyme was inhibited with citral (an inhibitor
of retinaldehyde dehydrogenase), the axon outgrowth-
promoting activity of the blastema diminished by approxi-
mately 40% (Prince and Carlone, 2003). This work strongly
suggested that the blastema was producing RA, which could
act to guide regenerating axons to their appropriate targets in
the regenerating limb. Because RA is a small, lipophilic
molecule, it seems likely that it could serve as a diffusible
factor, capable of guiding regenerating neurons over
significant distances. Indeed, both developing limb budsFig. 4. Local application of RA or a closely cultured secondary blastema sh
representation of (A) spinal cord and bead co-culture or (B) spinal cord and blastem
RA soaked bead (~300 Am). (B) Photo of another spinal cord explant cultured to
monitored 3 days after culture with beads or blastemas. Scale bar = 50 Am.and regeneration blastemas contain retinoids, including RA
(Scadding and Maden, 1994; Scott et al., 1994).
Maden et al. (1996), using an RA-deficient quail embryo
model system, have demonstrated that RA is necessary for
appropriate outgrowth of embryonic neurons in vivo. When
quail embryos develop in the absence of endogenous RA,
outgrowth from the neural tube is minimal, and if outgrowth
is present, it is chaotic and misdirected.
In vitro, RA has been shown to elicit outgrowth and
promote survival in axolotl and mouse embryo spinal cord
cultures and also in DRG cultures from a variety of
vertebrates (Corcoran et al., 2000; Hunter et al., 1991;
Maden et al., 1998; Prince and Carlone, 2003). Experiments
have also shown that RA can act as a chemoattractant
molecule, capable of dictating the direction of outgrowth
from chick embryo neural tube cells (Maden et al., 1998).
All these data strongly support a role for RA in directed
axonal outgrowth.
In contrast, Tonge and LeClere (2000) previously
suggested that RA, either alone, or in combination with
NGF, failed to induce axon outgrowth from axolotl DRG-
peripheral nerve explants. It is possible that concentration,
culture conditions, tissue-specific or species-specific differ-
ences could underlie the discrepancy in our results. For
example, our explants were cultured in 107 M RA on low
molecular weight poly-l-lysine. These conditions elicited a
threefold increase in the number of axons compared to
vehicle-treated controls. In contrast, the explants of Tonge
and LeClere (2000) were cultured in lower concentrations of
RA (108 to 109 M) and were maintained in matrigel.
Hunter et al. (1991) previously showed that there was a
threshold concentration of 108 to 109 M RA, below
which stimulation of outgrowth from axolotl spinal cord
neurons was significantly reduced. Furthermore, concen-owed similar abilities to direct axonal outgrowth. Above: diagrammatic
a co-culture. Below: (A) photo of spinal cord cultured to the lower left of an
the lower right of a secondary blastema (less than 1 mm). Explants were
Fig. 5. RAR antagonists significantly decreased RA-induced axonal outgrowth. Above: representative photos of spinal cord explants treated with (A) RA and
DMSO or (B) RA and LE135. Below: graph depicting significant reduction in RA-induced axons outgrowth in the presence of RAR antagonists. The number
of axons was counted 72 h after treatment with RAR antagonists in the presence or absence of RA. *RA treatment elicited significantly more axons than
antagonist solutions and controls (P b 0.05). Scale bar = 50 Am.
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toxic) in eliciting outgrowth from explants of the day 13.5
mouse embryo spinal cord (Corcoran et al., 2002). Scadding
and Maden (1994) have also estimated the concentrations of
endogenous RA in the posterior quadrant of urodele
amphibian limb blastema mesenchyme to be greater than
107 M. This physiological concentration is the same as that
used in the present study and in other studies showing
effective growth and survival in RA.
In addition to our results on neural outgrowth, we have
provided the first evidence that RA can act as a guidance
factor to direct the growth of neurons from adult newt CNS
tissue. We applied RA-soaked AG 1-X2 beads to cultures
at distances up to 1 cm from the spinal cord explants.
Axonal outgrowth was consistently directed towards the
beads, and was predominantly seen in that half of the
explant directly opposed to the bead. When beads were
cultured closer, axons could be seen contacting the surface
of the beads (data not shown). Previous studies demon-
strating RA chemotaxis have employed dissociated embry-
onic neural tube cells cultured in a Dunn chamber (Maden
et al., 1998). This apparatus provides a means of
generating a stable concentration gradient of RA (or any
other soluble molecule) in vitro (Zicha et al., 1991).
Although we did not measure the production of stable
gradients of RA in this study, AG 1-X2 beads are well knownto provide a stable continual source of RA in vitro (Tamura et
al., 1990).
As found by others, we also demonstrated that blastemas
were capable of directing axon outgrowth (Bauduin et al.,
2000; Tonge and LeClere, 2000; Tonge et al., 2004). In our
case, directed outgrowth was only observed when blastemas
were co-cultured within 1 mm of the spinal cord explant, a
result consistent with that of Bauduin et al. (2000). At
distances greater than 1 mm, axons were randomly
distributed around the circumference of the spinal cord
explant. The directed outgrowth was also seen when spinal
cord explants were co-cultured with secondary blastemas
(blastemas derived from a second amputation of the same
limb). However, the chemotactic response and overall
neurotrophic activity of secondary blastemas was signifi-
cantly reduced compared to the effects of primary blastemas
of equivalent size and morphology. Secondary blastemas
regenerate much more rapidly than primary blastemas
(Wallace, 1981). The molecular basis for this increased
regeneration rate is unknown, but our results suggest that
perhaps the reciprocal interaction between blastema mesen-
chyme and regrowing peripheral nerves is altered such that
the secondary blastema produces less RA for axon out-
growth. In support of this idea, Scadding and Maden (1994)
have shown that the endogenous concentrations of retinoids
fluctuate both spatially and temporally in the blastema
Fig. 6. RARh antagonists significantly decreased total axonal outgrowth induced by primary blastemas. Above: (A, B) Representative photos of spinal cord
explants and primary blastema co-cultures taken 72 h after treatment with (A) antagonist vehicle solution or (B) LE135. Blastema was cultured to the upper
right of explant in pictured experiments (A and B). **Primary blastema co-cultures (DMSO control) showed significantly more axons when compared to
primary blastemas and LE135 (P b 0.01). Scale bar = 50 Am.
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levels of RA in secondary blastemas exist at this time.
It is possible that the blastema is producing multiple
factors capable of guiding axons to their targets in the
regenerating limb. Several factors, including the neuro-
trophins, are able to stimulate axon outgrowth in vitro. It is
unlikely, however, that the limb blastema-derived activity
can be wholly accounted for by the presence of neuro-
trophins such as NGF, BDNF, NT-3, NT-4, GDNF, HGF,
and various FGFs found in these tissues. For example,
experiments blocking neurotrophin receptors with k252a, or
using trk-IgG chimeras to sequester the ligands, failed to
inhibit the neurotropic activity produced by blastemas
(Tonge and LeClere, 2000; Tonge et al., 2004). Bauduin
et al. (2000) have also suggested that the neurotropic
activity present in blastema-conditioned media resides in a
low molecular weight (b15,000 Da), heat-stable protease-
sensitive factor. Though RA fulfills the requirement of being
a low molecular weight substance, it is, however, heat
sensitive and protease insensitive.
In the present study, perhaps the most compelling
argument in support of a role for endogenous, blastema-
derived RA in the stimulation of neurite growth comes from
our results with the retinoic acid receptor antagonist LE135.
We showed that addition of the antagonist almost com-
pletely abolished the effects of 107 M RA on spinal cordaxon outgrowth. More importantly, LE135 also completely
abolished the stimulatory effects of co-cultured blastemas
on both axon number and direction of growth. LE135 alone
had neither a stimulatory nor an inhibitory effect on axonal
outgrowth compared to both vehicle-treated and untreated
control spinal cords.
These results with LE135 are consistent with the
existence and expression of an RARh isoform in the adult
newt central nervous system. In the human, rat, and mouse,
there are a, h, and g subtypes of both the RARs and RXRs
(which bind and mediate the effects of 9-cis retinoic acid),
each with multiple isoforms. In the newt, both RARa and y
(which is equivalent to the mammalian RARg) had
previously been reported (Ragsdale and Brockes, 1991;
Ragsdale et al., 1989, 1992; Maden and Hind, 2003). Until
now, however, there was no consistent evidence supporting
expression of an RARh in the newt CNS (Maden and Hind,
2003). Del Rincon and Scadding (2002), however, have
shown that LE135 inhibits limb regeneration in axolotls,
suggesting a role for RARh in the reestablishment of pattern
during limb regeneration. We have recently cloned a newt
RARh homologue (Carter et al., 2005), and in preliminary
studies, have demonstrated that its expression is maintained
in the adult spinal cord and brain and is upregulated after
amputation in both the tail and limb (unpublished). It
appears from our results that this isoform mediates the
J.M. Dmetrichuk et al. / Developmental Biology 281 (2005) 112–120120effects of RA on neuronal outgrowth in adult tissues as it
does in the mammal during embryogenesis (Corcoran et al.,
2002). In contrast to mammals, however, the expression of
this newt receptor isoform is maintained in the adult spinal
cord, and may contribute to the ability of adult newt CNS
tissue to regenerate.
In conclusion, it is likely that the blastema produces
multiple factors that act on regrowing peripheral nerves
during the course of urodele limb regeneration, with specific
factors perhaps affecting specific populations of neurons.
The present data argue for a significant contribution of
endogenous RA in this process and highlight the diverse
nature of effects this small lipophilic molecule has in
development and regeneration.Acknowledgments
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